Skip to main content

Table 4 Prevalence of HCV antibody and HCV RNA among Gorgan prison participants

From: A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting

 

Total

Residents

New inmates

People on OAT

People with a history of OAT

People with no history of OAT

Prevalence, n (%)

n = 1892

n = 1482

n = 410

n = 621

n = 241

n = 949

HCV antibody

130 (6.9%)

111 (7.5%)

19 (4.6%)

71 (11.4%)

17 (7.1%)

38 (4.0%)

HCV RNA

90 (4.8%)

84 (5.7%)

6 (1.5%)

54 (8.7%)

10 (4.2%)

24 (2.5%)

  1. OAT opioid agonist therapy